FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316941743> ?p ?o ?g. }

• W2316941743 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCPancreatic cancer (PC) remains a therapeutic challenge with a rising incidence and unabated mortality. Gemcitabine (GEM), the current standard of care drug, is largely ineffective due to chemoresistance, thus underscoring the need for a refined understanding of the molecular mechanisms that drive drug-resistant nature of this malignancy. Recently, we have shown that CXCL12/CXCR4 signaling axis is involved in conferring chemoresistance to PC cells. Here, we explored the effect of GEM on this resistance mechanism and its functional consequences. Our data demonstrated that GEM upregulated CXCR4 expression in two PC cell lines (MiaPaCa and Colo357) in a dose- and time- dependent manner. GEM-induced CXCR4 expression was dependent on generation of reactive oxygen species (ROS) as it was abrogated upon pre-treatment of PC cells with radical scavenger N-acetyl-L-cysteine (NAC). CXCR4 upregulation by GEM correlated with time-dependent accumulation of p65/NF-κB and HIF-1α in the nucleus. An enhanced binding of p65/NF-κB and HIF-1α to the CXCR4 promoter was observed in chromatin immunoprecipitation assay in GEM-treated PC cells, while their silencing by RNA interference suppressed GEM-induced CXCR4 expression. ROS induction upon GEM treatment preceded the nuclear accumulation of p65/NF-κB and HIF-1α and suppression of ROS diminished these effects. Effect of ROS on p65/NF-κB and HIF-1α was mediated through activation of ERK1/2 and Akt and their pharmacological inhibition also suppressed GEM-induced CXCR4 upregulation. Lastly, our data demonstrated that GEM-treated PC cells were more motile and exhibited significantly greater invasiveness against a CXCL12 gradient. Altogether, these findings reinforces the role of CXCL12/CXCR4 signaling in GEM resistance and point toward an undesired effect of chemotherapy that is potentiation of invasion and spread of resistant tumor cells.Citation Format: Sumit Arora, Arun Bhardwaj, Seema Singh, Sanjeev K. Srivastava, Steven McClellan, William E. Grizzle, Laurie B. Owen, Ajay P. Singh. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through upregulation of CXCR4. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4794. doi:10.1158/1538-7445.AM2013-4794" @default.
• W2316941743 created "2016-06-24" @default.
• W2316941743 creator A5000959667 @default.
• W2316941743 creator A5028850036 @default.
• W2316941743 creator A5040229335 @default.
• W2316941743 creator A5049997842 @default.
• W2316941743 creator A5051921217 @default.
• W2316941743 creator A5054926074 @default.
• W2316941743 creator A5076077003 @default.
• W2316941743 creator A5090389591 @default.
• W2316941743 date "2013-04-15" @default.
• W2316941743 modified "2023-09-25" @default.
• W2316941743 title "Abstract 4794: An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through upregulation of CXCR4." @default.
• W2316941743 doi "https://doi.org/10.1158/1538-7445.am2013-4794" @default.
• W2316941743 hasPublicationYear "2013" @default.
• W2316941743 type Work @default.
• W2316941743 sameAs 2316941743 @default.
• W2316941743 citedByCount "3" @default.
• W2316941743 countsByYear W23169417432018 @default.
• W2316941743 countsByYear W23169417432019 @default.
• W2316941743 countsByYear W23169417432021 @default.
• W2316941743 crossrefType "proceedings-article" @default.
• W2316941743 hasAuthorship W2316941743A5000959667 @default.
• W2316941743 hasAuthorship W2316941743A5028850036 @default.
• W2316941743 hasAuthorship W2316941743A5040229335 @default.
• W2316941743 hasAuthorship W2316941743A5049997842 @default.
• W2316941743 hasAuthorship W2316941743A5051921217 @default.
• W2316941743 hasAuthorship W2316941743A5054926074 @default.
• W2316941743 hasAuthorship W2316941743A5076077003 @default.
• W2316941743 hasAuthorship W2316941743A5090389591 @default.
• W2316941743 hasConcept C101762097 @default.
• W2316941743 hasConcept C104317684 @default.
• W2316941743 hasConcept C119056186 @default.
• W2316941743 hasConcept C121608353 @default.
• W2316941743 hasConcept C126322002 @default.
• W2316941743 hasConcept C127561419 @default.
• W2316941743 hasConcept C129470790 @default.
• W2316941743 hasConcept C13373296 @default.
• W2316941743 hasConcept C134320426 @default.
• W2316941743 hasConcept C150194340 @default.
• W2316941743 hasConcept C170493617 @default.
• W2316941743 hasConcept C173396325 @default.
• W2316941743 hasConcept C185592680 @default.
• W2316941743 hasConcept C190232843 @default.
• W2316941743 hasConcept C190283241 @default.
• W2316941743 hasConcept C2780210213 @default.
• W2316941743 hasConcept C2780258809 @default.
• W2316941743 hasConcept C2780492938 @default.
• W2316941743 hasConcept C48349386 @default.
• W2316941743 hasConcept C502942594 @default.
• W2316941743 hasConcept C55493867 @default.
• W2316941743 hasConcept C71924100 @default.
• W2316941743 hasConcept C75217442 @default.
• W2316941743 hasConcept C86803240 @default.
• W2316941743 hasConcept C95444343 @default.
• W2316941743 hasConceptScore W2316941743C101762097 @default.
• W2316941743 hasConceptScore W2316941743C104317684 @default.
• W2316941743 hasConceptScore W2316941743C119056186 @default.
• W2316941743 hasConceptScore W2316941743C121608353 @default.
• W2316941743 hasConceptScore W2316941743C126322002 @default.
• W2316941743 hasConceptScore W2316941743C127561419 @default.
• W2316941743 hasConceptScore W2316941743C129470790 @default.
• W2316941743 hasConceptScore W2316941743C13373296 @default.
• W2316941743 hasConceptScore W2316941743C134320426 @default.
• W2316941743 hasConceptScore W2316941743C150194340 @default.
• W2316941743 hasConceptScore W2316941743C170493617 @default.
• W2316941743 hasConceptScore W2316941743C173396325 @default.
• W2316941743 hasConceptScore W2316941743C185592680 @default.
• W2316941743 hasConceptScore W2316941743C190232843 @default.
• W2316941743 hasConceptScore W2316941743C190283241 @default.
• W2316941743 hasConceptScore W2316941743C2780210213 @default.
• W2316941743 hasConceptScore W2316941743C2780258809 @default.
• W2316941743 hasConceptScore W2316941743C2780492938 @default.
• W2316941743 hasConceptScore W2316941743C48349386 @default.
• W2316941743 hasConceptScore W2316941743C502942594 @default.
• W2316941743 hasConceptScore W2316941743C55493867 @default.
• W2316941743 hasConceptScore W2316941743C71924100 @default.
• W2316941743 hasConceptScore W2316941743C75217442 @default.
• W2316941743 hasConceptScore W2316941743C86803240 @default.
• W2316941743 hasConceptScore W2316941743C95444343 @default.
• W2316941743 hasLocation W23169417431 @default.
• W2316941743 hasOpenAccess W2316941743 @default.
• W2316941743 hasPrimaryLocation W23169417431 @default.
• W2316941743 hasRelatedWork W1518628133 @default.
• W2316941743 hasRelatedWork W2014103741 @default.
• W2316941743 hasRelatedWork W2023582138 @default.
• W2316941743 hasRelatedWork W2040595666 @default.
• W2316941743 hasRelatedWork W2051058993 @default.
• W2316941743 hasRelatedWork W2051825462 @default.
• W2316941743 hasRelatedWork W2063173107 @default.
• W2316941743 hasRelatedWork W2068569476 @default.
• W2316941743 hasRelatedWork W2070905705 @default.
• W2316941743 hasRelatedWork W2094609870 @default.
• W2316941743 hasRelatedWork W2137293812 @default.
• W2316941743 hasRelatedWork W2322940462 @default.
• W2316941743 hasRelatedWork W2501238599 @default.
• W2316941743 hasRelatedWork W2562027148 @default.
• W2316941743 hasRelatedWork W2740366217 @default.
• W2316941743 hasRelatedWork W2741578303 @default.
• W2316941743 hasRelatedWork W2809791434 @default.

• next